Expression Profiles of Genes—Potential Therapy Targets—and Their Relationship to Survival in Renal Cell Carcinoma


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

The main mechanisms of pathogenesis of clear cell renal cell carcinoma (CCRCC) are realized through the PI3K–AKT–mTOR and Ras–RAF–ERK signaling pathways. Targeted therapy is directed primarily at the genes and their encoded products that are components of these pathways. The levels of expression and coexpression of target genes were determined, and the difference in the functioning of the genes of one of the two major signaling pathways in tumors of CCRCC patients with different life duration (more and less than 3.5 years) and the relationship of the VEGFA gene expression level with the life duration was revealed.

Sobre autores

N. Apanovich

Research Centre for Medical Genetics

Email: karpukhin@med-gen.ru
Rússia, Моscow, 115478

M. Peters

Blokhin Russian Cancer Research Center

Email: karpukhin@med-gen.ru
Rússia, Moscow, 115478

P. Apanovich

Research Centre for Medical Genetics

Email: karpukhin@med-gen.ru
Rússia, Моscow, 115478

B. Kamolov

Blokhin Russian Cancer Research Center

Email: karpukhin@med-gen.ru
Rússia, Moscow, 115478

V. Matveev

Blokhin Russian Cancer Research Center; Faculty of Fundamental Medicine

Email: karpukhin@med-gen.ru
Rússia, Moscow, 115478; Moscow, 119192

E. Ginter

Research Centre for Medical Genetics

Email: karpukhin@med-gen.ru
Rússia, Моscow, 115478

A. Karpukhin

Research Centre for Medical Genetics

Autor responsável pela correspondência
Email: karpukhin@med-gen.ru
Rússia, Моscow, 115478

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Pleiades Publishing, Ltd., 2018